Phase 2 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who experience more than 10 breathing interruptions per hour during non-REM (lighter stage) sleep while lying on their back, as measured by a sleep study.
Who may not be able to join:
- People who have a medical condition other than well-controlled high blood pressure or mild diabetes.
- People who take any medication known to affect breathing, sleep, wakefulness, or muscle function.
- People who have a fear of enclosed spaces (claustrophobia).
- People who are unable to sleep on their back.
- People who have an allergy to any of the medications being tested in this trial.
- People who have a history of kidney stones, high calcium levels in the blood, overactive parathyroid glands, sarcoidosis, or too much vitamin D in the body.
- People who have an underlying heart condition, such as an irregular heartbeat.
- People who take psychiatric medications, including MAO inhibitors, SSRIs, SNRIs, or any of the specific medications being studied in this trial for an existing medical condition.
- Women who are pregnant.
- People who have high blood pressure in the lungs (pulmonary hypertension).
- People with severe sleep apnoea where the average blood oxygen level drops below 88% during sleep.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Apnea hypopnea Index (AHI, average number of events for every hour of sleep)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.